|
Program limiting prescription data mining
An AMA survey revealed that about 77 percent of physicians said they would opt out of sharing prescribing data with pharmaceutical representatives if given the chance. In response, the Physician Data Restriction Program (PDRP) was created.
In addition to restricting data, the Web-based program allows physicians to register a complaint about inappropriate pharmaceutical companies or representatives, or make a general observation about the use of prescribing data.
“We would like physicians to know and understand that, with the AMA’s program, they can shield their data from pharmaceutical representatives while still making it available for critically important patient safety and research issues,” explained Robert Musacchio, Ph.D., AMA’s senior vice-president of Publishing and Business.
Pharmaceutical representatives use prescribing data for customized sales and marketing to physicians and to review sales performances.
Opt out>>
Pharmaceutical companies are required to check the opt-out list at least quarterly.
|
